WALTHAM, Mass., Jan. 15, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NURO) will issue its fourth quarter 2018 financial results on Thursday morning January 24, 2019. A conference call will be held shortly afterwards at 8:00 a.m. Eastern. The call may be accessed in the United States at 844-787-0799, international at 661-378-9630. The confirmation code is 1262224. A replay will be available starting two hours after the call at 855-859-2056 United States and 404-537-3406 international using confirmation code 1262224. It will remain available for one week. The earnings release will be available on the Company's website www.NeuroMetrix.com under "Investor Relations".
NeuroMetrix is a commercial stage, innovation driven healthcare company combining neurostimulation and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The Company has two primary products. Quell® is an over-the-counter wearable therapeutic device for chronic pain. DPNCheck® is a rapid point-of-care test for diabetic neuropathy which is the most common long-term complication of Type 2 diabetes. For more information, please visit http://www.neurometrix.com.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
Source: NeuroMetrix, Inc.